Dechra Pharmaceuticals PLC
F:1PK0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dechra Pharmaceuticals PLC
F:1PK0
|
UK |
|
A
|
ArcBest Corp
F:AQY
|
US |
|
W
|
Wacker Chemie AG
XMUN:WCH
|
DE |
|
C
|
China Shenhua Energy Co Ltd
XHAM:IKF
|
CN |
|
E
|
Evercore Inc
F:QGJ
|
US |
|
Arvind Ltd
NSE:ARVIND
|
IN |
|
I
|
ITM Power PLC
XMUN:IJ8
|
UK |
|
B
|
Brady Corp
F:BRV
|
US |
|
C
|
Carlisle Companies Inc
DUS:CLE
|
US |
|
A
|
Allegheny Technologies Inc
XBER:ATD
|
US |
|
P
|
Perion Network Ltd
XBER:IW2
|
IL |
Wall St Price Targets
1PK0 Price Targets Summary
Dechra Pharmaceuticals PLC
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1PK0's stock price target?
Not Available
1PK0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Dechra Pharmaceuticals PLC?
Projected CAGR
9%
Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Dechra Pharmaceuticals PLC?
Projected CAGR
98%
Over the last 8 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 98%.